increas
frequenc
obes
worldwid
phenomenon
obes
defin
bodymass
index
bmi
center
diseas
control
prevent
http
wwwcdcgovobesityadultdefininghtml
world
health
organ
http
wwwwhointtopicsobesityen
associ
sever
debilit
chronic
diseas
includ
cardiovascular
diseas
diabet
mellitu
cancer
psoriasi
atherosclerosi
inflammatori
bowel
diseas
ibd
publish
data
indic
high
bmi
neg
correl
protect
immun
respons
obes
individu
highli
suscept
viral
bacteri
fungal
infect
obes
also
increas
risk
musculoskelet
disord
chronic
backlow
limb
pain
reduc
cognit
function
consid
potenti
risk
factor
alzheim
diseas
dementia
induc
ovulatori
infertil
increas
risk
earli
late
miscarriag
gestat
diabet
preeclampsia
complic
labor
deliveri
impair
respiratori
function
reduc
lung
expans
narrow
airway
lung
lead
asthma
obstruct
sleep
apnea
gener
obes
decreas
healthspan
lifespan
increas
prematur
mortal
significantli
increas
global
healthcar
cost
global
obes
epidem
affect
age
group
shown
recent
survey
conduct
million
peopl
countri
obes
neg
affect
immun
function
host
defens
mechan
one
reason
obes
inflammatori
condit
associ
chronic
activ
immun
system
consequ
local
system
inflamm
neg
associ
function
immun
system
previous
shown
system
chronic
inflamm
induc
intrins
inflamm
immun
cell
statu
immun
activ
associ
reduc
immun
respons
elev
serum
level
typic
old
age
neg
correl
cell
function
due
downregul
gene
transcript
cell
surfac
express
b
cell
also
affect
inflamm
shown
b
cell
elderli
individu
spontan
make
higher
amount
young
individu
b
cell
intrins
level
posit
correl
serum
importantli
b
cell
level
stimul
neg
correl
function
b
cell
vivo
vitro
stimul
influenza
vaccin
mitogen
respect
find
support
observ
inhibit
improv
b
cell
function
adipos
tissu
major
immunolog
tissu
contribut
system
inflamm
inflamm
character
infiltr
activ
immun
cell
secret
proinflammatori
mediat
cytokin
chemokin
well
adipokin
recruit
immun
cell
obes
recruit
immun
cell
differenti
inflammatori
subset
secret
addit
proinflammatori
molecul
contribut
mainten
local
system
inflamm
immun
cell
infiltr
includ
neutrophil
macrophag
cell
cell
nk
cell
innat
lymphoid
cell
cellular
composit
dynam
regul
acut
chronic
stimuli
includ
diet
bodi
weight
fast
age
associ
progress
declin
physiolog
function
lead
overt
chronic
diseas
frailti
mortal
physiolog
chang
includ
inflamm
lead
dysfunct
increas
secret
proinflammatori
mediat
immun
cell
infiltr
accumul
senesc
cell
process
altogeth
promot
lowgrad
chronic
inflamm
inflammag
insulin
resist
lead
transit
metabol
normal
obes
metabol
syndrom
occur
metaflamm
excess
nutrient
due
ineffici
glucos
metabol
promot
chronic
lowgrad
inflamm
metabol
hallmark
metaflamm
high
level
glucos
lipid
free
fatti
acid
reactiv
oxygen
speci
dysfunct
may
fundament
contributor
elev
risk
chronic
diseas
disabl
advers
health
outcom
elderli
review
show
experiment
evid
obes
link
higher
sever
rti
individu
differ
age
similar
shown
older
adult
potenti
mechan
respons
effect
discuss
focu
primarili
streptococcu
pneumonia
pneumococcu
infect
major
caus
morbid
mortal
us
caus
communityacquir
infect
pneumonia
otiti
media
mening
virus
caus
sever
rti
elderli
individu
includ
influenza
b
viru
respiratori
syncyti
viru
rsv
human
parainfluenza
viru
hpiv
rhinoviru
enteroviru
human
coronaviru
hcov
effect
obes
describ
viral
infect
mani
studi
investig
effect
obes
age
risk
influenza
viru
studi
analyz
effect
like
obes
shown
induc
defect
peripher
immun
cell
similar
induc
age
hypothes
multifactori
ageassoci
condit
paramet
might
concomitantli
associ
predisposit
older
adult
infect
influenza
viru
influenza
pandem
season
shown
obes
posit
associ
reduc
pulmonari
immun
defens
influenza
viru
also
pathogen
sever
report
clearli
indic
obes
morbidli
obes
individu
suscept
infect
influenza
viru
greater
sever
ill
infect
higher
rate
hospit
admiss
intens
care
unit
death
us
also
mani
countri
import
rsv
increasingli
recogn
hospit
adult
mainli
year
older
vaccin
prevent
rsv
infect
yet
avail
develop
effort
made
difficult
older
popul
due
ageassoci
decreas
immun
respons
rsv
infect
older
adult
caus
great
suffer
due
hospit
death
consid
social
burden
similar
season
influenza
clinic
manifest
rsv
infect
similar
caus
viral
respiratori
pathogen
studi
publish
rsvassoci
hospit
conduct
individu
year
hospit
acut
respiratori
ill
due
rsv
infect
older
adult
copd
andor
congest
heart
failur
shown
higher
risk
studi
conduct
middleag
older
adult
shown
rsv
infect
associ
obes
although
publish
studi
rsv
infect
obes
individu
hypothes
clinic
effect
similar
observ
older
adult
infect
gramposit
bacteria
streptococcu
pneumonia
pneumococcu
common
pathogen
nasopharynx
commonli
associ
pneumonia
repres
major
caus
morbid
mortal
risk
infect
higher
obes
vs
lean
individu
obes
associ
increas
risk
pneumonia
young
individu
studi
effect
pneumococcu
infect
obes
elderli
individu
limit
one
studi
report
incid
communityacquir
pneumonia
obes
patient
directli
associ
higher
bmi
age
group
howev
studi
convers
shown
obes
compar
lean
individu
like
surviv
admit
hospit
pneumococcu
infect
suggest
extra
energi
may
help
fight
infect
inflamm
adjust
potenti
confound
morbid
obes
associ
mortal
wherea
obes
associ
decreas
mortal
neither
morbid
obes
obes
associ
admiss
intens
care
unit
use
mechan
ventil
appar
controversi
result
may
due
fact
bmi
use
measur
adipos
result
may
differ
across
differ
studi
popul
bmi
crude
anthropometr
biomark
take
account
differ
import
measur
adipos
fat
mass
bodi
fat
distribut
measur
central
adipos
nutrit
statu
anoth
reason
may
due
differ
inflammatori
profil
particip
recruit
studi
exampl
obes
individu
high
circul
level
leptin
adipokin
secret
larg
amount
obes
may
enhanc
local
immun
respons
respiratori
pathogen
increas
host
defens
mechan
lung
leptin
strong
immunomodul
innat
adapt
immun
respons
increas
macrophag
phagocytosi
neutrophil
chemotaxi
natur
killer
cell
cytotox
well
b
cell
function
lead
increas
bacteri
clearanc
therefor
increas
leptin
level
could
increas
immun
respons
obes
individu
better
protect
infect
although
recent
studi
survivor
communityacquir
pneumonia
show
obes
paradox
could
attribut
differ
biomark
sever
inflammatori
pathway
studi
measur
four
marker
inflamm
includ
leptin
distinguish
pneumonia
caus
death
limit
conclus
inflamm
pathophysiolog
explan
obes
paradox
risk
infect
also
significantli
higher
individu
age
year
older
compar
younger
individu
tabl
summar
major
studi
cite
review
show
effect
age
comorbid
mortal
rate
infect
pneumococcu
avail
antimicrobi
treatment
patient
hospit
die
bacteri
pneumococc
pneumonia
mortal
rate
even
higher
older
adult
end
twentieth
centuri
mortal
rate
drop
individu
year
age
year
age
american
center
diseas
control
prevent
cdc
report
area
us
rate
invas
pneumococc
infect
among
older
adult
higher
infect
group
b
streptococcu
higher
haemophilu
influenza
higher
meningococcu
listeria
monocytogen
infect
rate
infect
elderli
individu
asia
africa
south
america
less
known
addit
obes
age
sever
risk
factor
identifi
includ
previou
viral
rti
influenza
rsv
well
chronic
ill
copd
congest
heart
failur
cerebrovascular
diseas
dementia
cancer
use
corticosteroid
also
shown
significantli
associ
risk
pneumococcu
infect
incid
pneumococc
pneumonia
increas
age
number
comorbid
atrisk
condit
similar
risk
highrisk
rheumatolog
condit
comorbid
higher
risk
compar
rheumatoid
condit
ageassoci
increas
lowgrad
chronic
inflamm
shown
associ
increas
suscept
pneumococc
infect
higher
diseas
sever
decreas
surviv
older
adult
gener
microbi
dysbiosi
drive
intestin
permeabl
transloc
bacteri
compon
bloodstream
sustain
inflamm
immun
activ
decreas
immun
respons
increas
gut
permeabl
age
induc
system
also
lung
inflamm
tissu
damag
shown
increas
level
circul
bacteri
toxin
lead
pulmonari
endotheli
damag
gut
microbiota
also
upper
rt
urt
microbiota
chang
age
contribut
streptococcu
pneumonia
colon
ineffici
clearanc
shown
studi
conduct
mice
urt
colon
sever
differ
speci
pathogen
continu
expos
bacteria
present
environ
surviv
nasal
oral
caviti
older
individu
due
loss
resist
colon
alter
immun
shown
efficaci
intranas
vaccin
live
attenu
influenza
viru
measur
mucos
iga
secret
depend
specif
bacteri
composit
nasal
caviti
suggest
import
nasal
microbiota
nasal
immun
whether
urt
microbiota
obes
individu
contribut
streptococcu
pneumonia
colon
remain
investig
studi
obes
associ
chang
gut
microbiota
phylumlevel
reduc
bacteri
divers
mice
human
mous
studi
identifi
intestin
microbiota
product
protect
host
pneumococcu
infect
shown
mechan
involv
briefli
shown
gut
microbiota
increas
phagocytosi
alveolar
macrophag
protect
tissu
damag
pneumococcusinduc
sepsi
human
studi
necessari
confirm
posit
result
obtain
mice
nurs
home
repres
one
set
outbreak
pneumococc
infect
elderli
vaccin
report
protect
elderli
individu
nurs
home
outbreak
pneumococc
infect
risk
pneumococc
infect
also
higher
individu
certain
ethnic
group
afroamerican
peopl
age
live
us
suscept
caucasian
individu
rate
infect
slightli
higher
older
afroamerican
popul
nativ
american
alaskan
higher
risk
pneumococc
diseas
individu
ethnic
group
popul
nativ
alaskan
well
nativ
american
apach
tribe
live
arizona
increas
risk
pneumococc
diseas
compar
nonn
popul
live
area
northern
canada
well
higher
risk
pneumococc
diseas
report
indigen
popul
higher
rate
multipl
chronic
condit
relat
colon
indigen
peopl
diet
mani
gener
may
part
explain
dispar
requir
studi
chronic
activ
innat
immun
system
consequ
local
system
inflamm
relat
obes
contribut
patholog
condit
cancer
atherosclerosi
ibd
obes
individu
increas
suscept
viral
bacteri
fungal
infect
outcom
infect
may
determin
host
factor
evid
compar
outcom
influenza
pneumococc
pneumonia
older
age
obes
contribut
seriou
complic
influenza
obes
appear
protect
seriou
complic
pneumococc
pneumonia
advanc
age
socal
obes
paradox
futur
studi
need
address
signific
gap
understand
interact
age
obes
multipl
chronic
condit
microbiom
particularli
relat
risk
complic
acut
rti
mechanist
studi
need
move
beyond
learn
epidemiolog
studi
develop
new
biomark
relat
prevent
therapeut
approach
improv
outcom
acut
respiratori
ill
person
multipl
chronic
condit
futur
studi
also
need
address
prevent
obes
improv
eat
habit
increas
physic
activ
way
fight
rti
inde
experiment
evid
show
weight
reduct
decreas
system
inflamm
improv
immun
respons
bacteri
viral
fungal
infect
sever
epidemiolog
studi
evalu
effect
diet
exercis
protect
subject
sever
diseas
associ
chronic
lowgrad
inflamm
reduc
risk
infecti
diseas
increas
respons
pathogen
reduc
burden
ill
healthrel
cost
jm
receiv
honoraria
sanofi
gsk
pfizer
particip
advisori
board
scientif
present
meet
relat
cost
travel
remain
author
declar
research
conduct
absenc
commerci
financi
relationship
could
constru
potenti
conflict
interest
